Evidence map›Paper›PMID 35880319›Full record

ArticleAnnals of clinical and translational neurology2022

PI4K2A deficiency causes innate error in intracellular trafficking with developmental and epileptic-dyskinetic encephalopathy.

Hormos Salimi Dafsari, Joshua G Pemberton, Elizabeth A Ferrer, Tony Yammine, Chantal Farra, Mohammad Hasan Mohammadi, Ehsan Ghayoor Karimiani, Narges Hashemi, Mirna Souaid, Sandra Sabbagh and 8 more

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Phosphatidylinositol 4-phosphate; A minor lipid with multiple personalities.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. An update on autophagy disorders.Journal of inherited metabolic disease · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. The PITT pathway: Keeping lysosomes young.Clinical and translational medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 6 countries.

Hormos Salimi Dafsari *Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Köln, Germany.ORCID 0000-0003-3483-5009
Joshua G Pemberton *Section on Molecular Signal Transduction, Program for Developmental Neuroscience, Eunice Kennedy Shriver NICHD, National Institutes of Health, Bethesda, Maryland, USA.
Elizabeth A FerrerSection on Molecular Signal Transduction, Program for Developmental Neuroscience, Eunice Kennedy Shriver NICHD, National Institutes of Health, Bethesda, Maryland, USA.
Tony YammineMedical Genetics Unit, Saint Joseph University, Beirut, Lebanon.
Chantal FarraMedical Genetics Unit, Saint Joseph University, Beirut, Lebanon.
Mohammad Hasan MohammadiDepartment of Pediatrics, Zabol University of Medical Sciences, Zabol, Iran.
Ehsan Ghayoor KarimianiMolecular and Clinical Sciences Institute, St. George's, University of London, Cranmer Terrace, London, UK.
Narges HashemiDepartment of Pediatric Neurology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mirna SouaidMedical Genetics Unit, Saint Joseph University, Beirut, Lebanon.
Sandra SabbaghDepartment of Genetics, Hotel Dieu de France Medical Center, Beirut, Lebanon.
Paria Najarzadeh TorbatiDepartment of Medical Genetics, Next Generation Genetic Polyclinic, Mashhad, Iran.
Suliman KhanCENTOGENE GmbH, Rostock, Germany.
Emmanuel RozeCNRS, INSERM, Institut du Cerveau (ICM), Sorbonne Université, Paris, 75013, France.
Andres Moreno-De-LucaDepartment of Radiology, Diagnostic Medicine Institute, Autism & Developmental Medicine Institute, Genomic Medicine Institute, Geisinger, Danville, Pennsylvania, USA.ORCID 0000-0002-2732-4043
Aida M Bertoli-AvellaCENTOGENE GmbH, Rostock, Germany.
Henry HouldenDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, Queen Square, London, UK.
Tamas BallaSection on Molecular Signal Transduction, Program for Developmental Neuroscience, Eunice Kennedy Shriver NICHD, National Institutes of Health, Bethesda, Maryland, USA.
Reza MaroofianDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, Queen Square, London, UK.ORCID 0000-0001-6763-1542
National Institutes of Health · USSaint Joseph University · LBCentogene (Germany) · DENIHR Queen Square Dementia Biomedical Research Unit · GBAutism & Developmental Medicine Institute · USCentre National de la Recherche Scientifique · FRHôtel-Dieu de France · LBMashhad University of Medical Sciences · IRSt George's, University of London · GBUniversity of Cologne · DEZabol University of Medical Sciences · IR

Funding

Characterizing the spectrum of genomic and phenotypic variation in cerebral palsyR01HD104938 · NICHD · GEISINGER CLINIC · PI Scott Myers · 2022 to 2026
$3.4M
NICHD NIH HHS R01 HD104938Wellcome TrustWellcome Trust WT093205Wellcome Trust WT104033AIA
6 · The paper itself

Abstract

objectiveIntracellular signaling networks rely on proper membrane organization to control an array of cellular processes such as metabolism, proliferation, apoptosis, and macroautophagy in eukaryotic cells and organisms. Phosphatidylinositol 4-phosphate (PI4P) emerged as an essential regulatory lipid within organelle membranes that defines their lipid composition and signaling properties. PI4P is generated by four distinct phosphatidylinositol 4-kinases (PI4K) in mammalian cells: PI4KA, PI4KB, PI4K2A, PI4K2B. Animal models and human genetic studies suggest vital roles of PI4K enzymes in development and function of various organs, including the nervous system. Bi-allelic variants in PI4KA were recently associated with neurodevelopmental disorders (NDD), brain malformations, leukodystrophy, primary immunodeficiency, and inflammatory bowel disease. Here, we describe patients from two unrelated consanguineous families with PI4K2A deficiency and functionally explored the pathogenic mechanism.

methodsTwo patients with PI4K2A deficiency were identified by exome sequencing, presenting with developmental and epileptic-dyskinetic encephalopathy. Neuroimaging showed corpus callosum dysgenesis, diffuse white matter volume loss, and hypoplastic vermis. In addition to NDD, we observed recurrent infections and death at toddler age. We further explored identified variants with cellular assays.

resultsThis clinical presentation overlaps with what was previously reported in two affected siblings with homozygous nonsense PI4K2A variant. Cellular studies analyzing these human variants confirmed their deleterious effect on PI4K2A activity and, together with the central role of PI4K2A in Rab7-associated vesicular trafficking, establish a link between late endosome-lysosome defects and NDD.

interpretationOur study establishes the genotype-phenotype spectrum of PI4K-associated NDD and highlights several commonalities with other innate errors of intracellular trafficking.

Indexed as

Epilepsy, GeneralizedMinor Histocompatibility AntigensNervous System MalformationsNeurodevelopmental DisordersPhosphotransferases (Alcohol Group Acceptor)HomozygoteHumansMinor Histocompatibility Antigensphosphatidylinositol phosphate 4-kinasePhosphotransferases (Alcohol Group Acceptor)

Identifiers

PMID35880319
PMCPMC9463957
OpenAlexW4287922744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.